“…For example, the pluripotential of cyclopropanols was recently demonstrated via late-stage functionalization, affording different derivatives of chlamydocin, a histone deacetylase inhibitor . Despite the obvious relevance of cyclopropanols in the construction of biologically relevant molecules, the development of novel and general methods for the formation of enantioenriched tertiary derivatives, , leading to β-nucleophilic ketone equivalents, has remained scarce. , The most conventional approaches to tertiary cyclopropanols include the cyclopropanation of enols using carbenoid species (Scheme a) ,, or the Kulinkovich cyclopropanation of esters (Scheme b), − both of which are rarely amenable to the formation of enantioenriched products and possess considerable limitations in terms of practicality and sustainability . A distinct approach, which consists of introducing the C(1)-substituent last via nucleophilic addition to a cyclopropanone surrogate, is not general mainly due to the absence of suitable precursors readily accessible in enantioenriched form (Scheme c).…”